Associate Professor Henry Klar Yaggi

New Haven (United States of America)

Follow

Contributor content

Obstructive sleep apnoe and cardiovascular, heart failure and mortality outcomes with empagliflozin versus placebo in the EMPA-REG OUTCOME trial

Presentation

Obstructive sleep apnoe and cardiovascular, heart failure and mortality outcomes with empagliflozin versus placebo in the EMPA-REG OUTCOME trial

ESC 365 is supported by

novartis

Explore sponsored resources